{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:43:07Z","timestamp":1790804587858,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejim.2021.05.040","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T04:03:19Z","timestamp":1624507399000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-3169","authenticated-orcid":false,"given":"Nihal","family":"Martis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Jamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Bagnis-Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pouteil-Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9928-4351","authenticated-orcid":false,"given":"Claire","family":"Presne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-8552","authenticated-orcid":false,"given":"Steven","family":"Grang\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Coindre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Wynckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Kanouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Hi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.05.040_bib0001","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.05.040_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejim.2021.05.040_bib0003","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.05.040_bib0004","doi-asserted-by":"crossref","first-page":"e2891","DOI":"10.1097\/MD.0000000000002891","article-title":"Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER)","volume":"95","author":"Galindo-Izquierdo","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0005","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0006","doi-asserted-by":"crossref","first-page":"e1598","DOI":"10.1097\/MD.0000000000001598","article-title":"Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura","volume":"94","author":"Roriz","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0007","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2021.05.040_bib0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/asheducation-2016.1.217","article-title":"Atypical hemolytic uremic syndrome","volume":"2016","author":"Afshar-Kharghan","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ejim.2021.05.040_bib0009","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2021.05.040_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/RHU.0000000000000425","article-title":"Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study","volume":"22","author":"Barrera-Vargas","year":"2016","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0011","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3899\/jrheum.170811","article-title":"Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles","volume":"45","author":"Yue","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0012","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature","volume":"49","author":"Kello","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.05.040_bib0013","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0014","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.ackd.2019.08.012","article-title":"Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus","volume":"26","author":"Kotzen","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ejim.2021.05.040_bib0015","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.05.040_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177894","article-title":"Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome","volume":"12","author":"Jamme","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2021.05.040_bib0017","first-page":"1400","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology","volume":"71","author":"Aringer","year":"2019","journal-title":"(Hoboken, N.J.)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0018","article-title":"A Comparison of 2019 EULAR\/ACR SLE Classification Criteria with Two Sets of Earlier SLE Classification Criteria","author":"Petri","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0019","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.ejim.2021.05.040_bib0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2021.05.040_bib0021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis & Rheumatology (Hoboken, N.J.)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0022","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2021.05.040_bib0023","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3324\/haematol.2011.049676","article-title":"Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience","volume":"97","author":"Benhamou","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2021.05.040_bib0024","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2021.05.040_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited","volume":"15","author":"Weening","year":"2004","journal-title":"JASN"},{"key":"10.1016\/j.ejim.2021.05.040_bib0026","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/rheumatology\/kez167","article-title":"Thrombotic microangiopathy associated with anti-neutrophil cytoplasmic antibody-associated vasculitis: a French nationwide retrospective case-control study and literature review","volume":"58","author":"Dellal","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0027","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/rheumatology\/keq311","article-title":"Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan","volume":"50","author":"Chen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2021.05.040_bib0028","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.05.040_bib0029","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2215\/CJN.02870311","article-title":"Evaluation of clinical outcomes and renal vascular pathology among patients with lupus","volume":"7","author":"Barber","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0030","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10067-017-3912-2","article-title":"Sj\u00f6gren's syndrome initially presented as thrombotic thrombocytopenic purpura in a male patient: a case report and literature review","volume":"37","author":"Xu","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0031","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3109\/0886022X.2014.917764","article-title":"Thrombotic microangiopathy complicating newly diagnosed Sj\u00f6gren's syndrome in a dialysis patient","volume":"36","author":"Cheng","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.ejim.2021.05.040_bib0032","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","article-title":"Clinical and morphological features of kidney involvement in primary Sj\u00f6gren's syndrome","volume":"16","author":"Bossini","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2021.05.040_bib0033","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3899\/jrheum.131210","article-title":"Scleroderma renal crisis","volume":"41","author":"Mouthon","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0034","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2021.05.040_bib0035","first-page":"149","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.ejim.2021.05.040_bib0036","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.transci.2010.10.003","article-title":"Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis","volume":"43","author":"Loo","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ejim.2021.05.040_bib0037","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.05.040_bib0038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12882-020-01888-5","article-title":"A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"21","author":"Wright","year":"2020","journal-title":"BMC Nephrology"},{"key":"10.1016\/j.ejim.2021.05.040_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.05.007","article-title":"The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review","volume":"92","author":"Cervera","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2021.05.040_bib0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","article-title":"Scleroderma renal crisis","volume":"44","author":"Bose","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2021.05.040_bib0041","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-20315-3_10","article-title":"Microangiopathy in Cancer: Causes, Consequences, and Management","volume":"179","author":"Thomas","year":"2019","journal-title":"Cancer Treat Res"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521001990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521001990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:34:42Z","timestamp":1760607282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521001990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":41,"alternative-id":["S0953620521001990"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.05.040","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}